Pesampator

DB11843InvestigationalSmall molecule

PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing Loss, Sensorineural.

Chemical structure of Pesampator
Mechanism
Curator reviewed
Formula / weight
C18H20N2O4S2 · 392.49 g/mol (avg)
Code names
BIIB-104 · PF-04958242 · PF-4958242

Resolves to

Compound
UNII9G1A824CC2CAS1258963-59-5PubChem49853967
Structure
InChIKeyTTYKUKSFWHEBLI-DLBZAZTESA-NSMILESCC(C)S(=O)(=O)N[C@H]1COC[C@H]1OC1=CC=C(C=C1)C1=CC=C(S1)C#N
Targets
P42262GRIA2

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Pesampator, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In